Volume 20 • Issue 9

April 29, 2020

VYVANSE CHEWABLES - PUBLIC LISTING UPDATE

VYVANSE chewable tablets are now on the Ontario Drug Benefit formulary (General Benefit with Therapeutic Notes). Click HERE to learn more.
VYVANSE is a registered trademark used under license from Shire LLC. Shire Pharma Canada ULC, now a part of Takeda, is the market authorization holder in Canada. Takeda and the Takeda Logo are trademarks of Takeda Pharmaceutical Company Limited, used under license. Copyright © 2020 Takeda Pharmaceutical Company Limited. All rights reserved.

THE COVID CONVERSATIONS

The COVID Conversations is CPhA’s open access webinar series designed to support pharmacists during the COVID-19 pandemic. Canadian Pharmacists Association

•	Supporting Pharmacists’ Mental Health and Wellness (April 22, 2020)

•	Day In the Life of Community Pharmacists During COVID-19: Stories from the Front Line (April 14, 2020)

•	Personal Protective Equipment (PPE): Suggested Best Practices for Pharmacies During the COVID-19 Pandemic (April 2, 2020)

•	Managing COVID-19 Day-to-Day: More Answers to Pharmacists’ FAQs. (March 23, 2020)

•	What Pharmacists Need To Know About COVID-19 (March 11, 2020)